1. National Cancer Institute Surveillance Epidemiology and End Results Program. Cancer Stat Facts: Melanoma of the Skin, 2022. https://seer.cancer.gov/statfacts/html/melan.html.
2. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Melanoma: Cutaneous. Version 3.2022-April 11, 2022. https://www.nccn.org/professionals/physician_gls/PDF/melanoma.pdf.
3. Miller R, Walker S, Shui I, Brandtmuller A, Cadwell K, Scherrer E. Epidemiology and survival outcomes in stages II and III cutaneous melanoma: a systematic review. Melanoma Manage. 2020;7(1):MMT39.
4. Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(6):472–92.
5. Garbe C, Keim U, Amaral T, et al. Prognosis of patients with primary melanoma stage I and II according to American Joint Committee on Cancer Version 8 Validated in two independent cohorts: implications for adjuvant treatment. J Clin Oncol. 2022;20:1.